A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK.
EC approves Daiichi Sankyo’s Vanflyta for acute myeloid leukaemia
Daiichi Sankyo’s Vanflyta is designed for FTL3-ITD-positive AML patients. Credit: Nemes Laszlo / Shutterstock.com. The European Commission (EC) has granted approval for Daiichi Sankyo’s Vanflyta (quizartinib) for